Pharmacy Benefit Managers Support Increased Transparency in Prescription Drug Supply Chain
May 20, 2019
(Washington, D.C.) — As the Energy and Commerce Subcommittee on Health examines ways to bring more transparency to prescription drug...
PCMA Statement on the Administration’s Medicare Part D Rule
May 16, 2019
(Washington, D.C.) —Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Administration’s final...
Independent Drugstore Lobby Agenda Increases Prescription Drug Costs in New York
May 14, 2019
(Washington, D.C.) – As independent drugstore lobbyists descend on Albany for their special interest lobby day, the Pharmaceutical Care Management Association...
OUR NEXT CONFERENCE
PCMA Annual Meeting
September 23 & 24, 2019
Scottsdale, AZ
Join us for the industry’s premier executive conference. The event is tailored specifically for senior executives from PBMs and their affiliated business partners – most notable drug manufacturers.
Learn MoreABOUT OUR INDUSTRY
PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others. PBMs are projected to save employers, unions, government programs, and consumers $654 billion— up to 30 percent—on drug benefit costs over the next decade.